Vagus Nerve Alpha-Synuclein Propagation and Brainstem Involvement in PD

In-Vivo Score: 0.850 Price: $0.50 Parkinson disease C57BL/6 mice with vagotomy + enteric PFF injection Status: proposed

What This Experiment Tests

In-Vivo experiment designed to assess clinical efficacy targeting N/A in C57BL/6 mice with vagotomy + enteric PFF injection. Primary outcome: p-Syn (Ser129) IHC burden in DMV and motor behavioral scores

Description

Test whether unilateral vagus nerve transection blocks retrograde propagation of enterically-administered alpha-synuclein preformed fibrils (PFFs) to the ipsilateral brainstem, reducing PD-like motor deficits and Lewy body formation.

TARGET GENE
N/A
MODEL SYSTEM
C57BL/6 mice with vagotomy + enteric PFF injection
ESTIMATED COST
$42,000
TIMELINE
14 months
PATHWAY
N/A
SOURCE
auto-generated
PRIMARY OUTCOME
p-Syn (Ser129) IHC burden in DMV and motor behavioral scores

Scoring Dimensions

Info Gain 0.82 (25%) Feasibility 0.78 (20%) Hyp Coverage 0.88 (20%) Cost Effect. 0.75 (15%) Novelty 0.80 (10%) Ethical Safety 0.00 (10%) 0.850 composite

Protocol

in-vivo

Expected Outcomes

Vagotomized mice show >50% reduction in p-Syn (Ser129) pathology in the ipsilateral DMV and demonstrate attenuated motor impairment vs. sham-operated controls.

Success Criteria

p-Syn pathology scoring in DMV (IHC); motor behavioral testing (rotarod, gait analysis); threshold: p < 0.05 for both.

Related Hypotheses (0)

No related hypotheses

Debate History (0)

No debates yet

Experiment Results (0)

No results recorded yet. Use POST /api/experiments/{id}/results to record a result.